Showing results (1791-1800 of 2,011) with videos related to

Sort By:
Pageof 202
Annals of Neurology|August 11, 2017
Natural history of Charcot-Marie-Tooth disease during childhoodKayla M D Cornett, Manoj P Menezes, Rosemary R Shy, et al.
Journal of Neuromuscular Diseases|March 13, 2023
Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG)Richard S Finkel, Basil T Darras, Jerry R Mendell, et al.
Journal of Hepatology|October 3, 2021
ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLDKathleen E Corey, Rebecca Pitts, Michelle Lai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 27, 2025
NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β-TrCP1/FBXO5 AxisYao Tong, Travis B Lear, Ferhan Tuncer, et al.
World Journal of Gastrointestinal Pathophysiology|September 30, 2025
Jejunal diverticular disease: A gastrointestinal bleeding enigmaRoberto Anaya-Prado, Victor J Avalos-Herrera, Aldo A Silva-Esparza, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
Neurology|August 8, 2014
Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRSIshu Arpan, Rebecca J Willcocks, Sean C Forbes, et al.
Annals of Neurology|February 27, 2013
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophyKevin M Flanigan, Ermelinda Ceco, Kay-Marie Lamar, et al.
Journal of Neuromuscular Diseases|January 22, 2024
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE RegistryLaurent Servais, John W Day, Darryl C De Vivo, et al.
Pageof 202